The PICHFORK (Pain InCHildren Fentanyl OR Ketamine) trial comparing the efficacy of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries: study protocol for a randomized controlled trial

Trials

Rose Chapman³  Trentham Furness³  Robert Seith²  Diana Egerton-Warburton¹  Robert Meek²  Andis Graudins¹ 

[1] Department of Emergency Medicine, Monash Medical Centre, 264 Clayton Road, Clayton, VIC 3168, Australia;Monash Health Emergency Medicine Program, Monash Health, Clayton, VIC, Australia;School of Nursing, Midwifery and Paramedicine, Australian Catholic University, Fitzroy, VIC, Australia

关键词: Analgesia;    Pain;    Children;    Musculoskeletal injury;    Fentanyl;    Intranasal ketamine;   

Others  :  1093475
DOI  :  10.1186/1745-6215-14-208

 received in 2013-01-30, accepted in 2013-07-04,  发布年份 2013

【 摘 要 】

Background

The effectiveness of intranasal (IN) fentanyl as an analgesic for painful pediatric limb injuries in the Emergency Department (ED) has been reported previously. However, efficacy of IN ketamine in sub-dissociative doses is not well studied in the ED setting. A non-blinded pilot study undertaken by this study group suggested that IN ketamine showed similar analgesic effectiveness to that reported with IN fentanyl in similar non-blinded studies. The aim of this randomized, controlled, equivalence trial is to compare the analgesic effect of sub-dissociative dose IN ketamine with IN fentanyl for children with isolated musculoskeletal limb injuries.

Methods/Design

This is a prospective, randomized, controlled, double-blind equivalence trial of children agedthree to thirteen years and less than 50 kg body weight, with isolated musculoskeletal limb injury, presenting to the ED with moderate to severe pain, defined as a verbal response of at least six to a standard 11-point scale (0 = none, 10 = worst pain imaginable). Pain score, sedation, satisfaction with analgesic intervention, and adverse effects will be assessed over a 60 minute interval for each participant. Intranasal ketamine (1 mg/kg) or fentanyl (1.5 microgram/kg) will be administered via blinded syringe and mucosal atomization device in a standardized volume at 0.03 ml/kg, with a maximum volume of 1.5 ml divided equally to both nares. Participants will also receive 10 mg/kg ibuprofen orally. The primary outcome measure will be median change in pain score from pre-administration to 30 minutes post-administration. Non-parametric Mann–Whitney U tests will be computed to compare median change in the primary outcome measure for IN ketamine and fentanyl. A sample size of 36 participants per group is needed to detect the expected 40 mm reduction in pain rating with a 95% confidence interval (CI) no greater than ± 10 mm at 30 minutes. Rescue analgesia will be given as IN fentanyl or intravenous morphine.

Discussion

This is the first randomized-controlled trial comparing the efficacy of these two analgesic agents via the intranasal route. If IN ketamine is found to be equally effective to IN fentanyl for this indication, it will provide another analgesic agent that may be considered for the relief of acute pain in children in the ED.

Trial registration

Australian New Zealand Clinical Trials RegistryACTRN12612000795897.

【 授权许可】

   
2013 Graudins et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Pointer S, Helps Y: Trends in hospitalized childhood injury in Australia 1999 to 2007. Injury research and statistics series number 75,catalognumber INJCAT 151. Canberra: Australian Institute of Health and Welfare; 2012.
• [2]ACEM: Australian College for Emergency Medicine, Australian College for Emergency Nursing, College of Emergency Nursing Australasia Joint Policy Statement Emergency Department Pain Management. Melbourne, Australia: Australasian College for Emergency Medicine; 2009.
• [3]Goldman RD: Intranasal drug delivery for children with acute illness. Curr Drug Ther 2006, 1(1):127-130.
• [4]Rickard C, O’Meara P, McGrail M, Garner D, McLean A, Le Lievre P: A randomized controlled trial of intranasal fentanyl versus intravenous morphine for analgesia in the prehospital setting. Am J Emerg Med 2007, 25(8):911-917.
• [5]Crellin D, Ling RX, Babl FE: Does the standard intravenous solution of fentanyl (50 mcg/mL) administered intranasally have analgesic efficacy? Emerg Med Australas 2010, 22(1):62-67.
• [6]National Institute of Clinical Studies: Emergency care acute pain management manual, National Health and Medical Research Council. Canberra, Australia: ACT; 2011.
• [7]Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc L, et al.: Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Therpeut 2012, 134(3):366-379.
• [8]Borland M, Jacobs I, King B, O’Brien D: A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med 2007, 49(3):335-340.
• [9]Andrews C, Prys-Roberts C: Fentanyl - a review. Clin Anesthesiol 1983, 1:97-112.
• [10]Wolfe TR, Braude DA: Intranasal medication delivery for children: a brief review and update. Pediatrics 2010, 126(3):532-537.
• [11]Craven R: Ketamine. Anaesthesia 2007, 62(S1):48-53.
• [12]Herd D, Anderson BJ: Ketamine disposition in children presenting for procedural sedation and analgesia in a children’s emergency department. Paediatr Anaesth 2007, 17(7):622-629.
• [13]Reid C, Hatton R, Middleton P: Case report: prehospital use of intranasal ketamine for pediatric burn injury. Emerg Med J 2011, 28:328-329.
• [14]Yeaman F, Oakley E, Meek R, Graudins A: Sub-dissociative dose intranasal ketamine for limb injury pain in children in the emergency department: a pilot study. Emerg Med Australas 2013, 25(2):161-167.
• [15]Altman DG, Bland JM: How to randomize. Brit Med J 1999, 319(7211):703-704.
• [16]Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Tremper K, Naughton N: Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth 2002, 88(2):241-245.
• [17]Bird SB, Dickson EW: Clinically significant changes in pain along the visual analog scale. Ann Emerg Med 2001, 38:639-643.